source
- Biopharma's pay oddities of 2025: Executive perks and eccentricitiesIn combing through thousands of C-suite pay packages worth billions of dollars, it’s rare for a line item to stick out. Every once in a while, a biopharma company discloses perks that go beyond the…Endpoints · 1mo ago↗ source
- STAT+: Pharmalittle: We’re reading about a discontinued cancer drug, a Novo security breach, and moreThe nonprofit Blood Cancer United is buying the remaining supplies of a discontinued investigational cancer drug, LuveltaSTAT · 1mo ago↗ source
- Chile offers new data on food warning label efficacyKennedy's "publicly" "available" "calendar," drinking during pregnancy, and more health news from Morning RoundsSTAT · 1mo ago↗ source